INVO - INVO BioScience GAAP EPS of -$0.21 misses by $0.09 revenue of $0.24M beats by $0.01M
- INVO BioScience press release ( NASDAQ: INVO ): Q3 GAAP EPS of -$0.21 misses by $0.09 .
- Revenue of $0.24M (+9.1% Y/Y) beats by $0.01M .
- As of September 30, 2022, the Company had approximately $0.3 million in cash.
- Shares +0.84% .
For further details see:
INVO BioScience GAAP EPS of -$0.21 misses by $0.09, revenue of $0.24M beats by $0.01M